Australia - English - Department of Health (Therapeutic Goods Administration)

kls martin australia pty ltd - 35850 - dental impression tray, reusable - perforated dental impression tray - jaw.

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - rivaroxaban - film-coated tablet - 15 milligram(s) - rivaroxaban

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - rivaroxaban - film-coated tablet - 20 milligram(s) - rivaroxaban

Singapore - English - HSA (Health Sciences Authority)

steril medical pte ltd - general hospital - sterile, disposable wound drainage system to be used for the removal of sero-sanguineous fluid from the wound site in order to assure proper wound approximation and healing, to alleviate dead space, and to reduce potential complications.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

tessara pty ltd - sodium metabisulfite - slow release generator (inc. flea collars) - sodium metabisulfite mineral-sodium active 358.3 g /kg - fungicide

European Union - English - EMA (European Medicines Agency)

astrazeneca ab - dapagliflozin propanediol monohydrate - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - drugs used in diabetes - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance.in addition to other medicinal products for the treatment of type 2 diabetes.for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4.4, 4.5 and 5.1.heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure.chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.

European Union - English - EMA (European Medicines Agency)

kyowa kirin holdings b.v. - naloxegol oxalate - constipation; opioid-related disorders - peripheral opioid receptor antagonists, drugs for constipation - treatment of opioid-induced constipation (oic) in adult patients who have had an inadequate response to laxative(s).

Israel - English - Ministry of Health

abir therapeutics ltd, israel - naloxegol as oxalate - film coated tablets - naloxegol as oxalate 12.5 mg - naloxegol - moventig is indicated for the treatment of opioid-induced constipation (oic) in adult patients who have had an inadequate response to laxative(s).

Israel - English - Ministry of Health

abir therapeutics ltd, israel - naloxegol as oxalate - film coated tablets - naloxegol as oxalate 12.5 mg - naloxegol - moventig is indicated for the treatment of opioid-induced constipation (oic) in adult patients who have had an inadequate response to laxative(s).